The challenges associated with molecular targeted therapies for glioblastoma

Area of Science:

• Neuro-oncology
• Cancer Therapeutics
• Molecular Medicine

Background:

• Glioblastoma (GBM) is the most aggressive adult malignant brain tumor.
• Current standard treatment (radiation with temozolomide) has shown limited improvement.
• Personalized medicine approaches are revolutionizing cancer care in other malignancies.

Purpose of the Study:

• To review the challenges in applying personalized molecular targeted therapy to GBM.
• To assess the feasibility of GBM treatment mirroring strategies used for other cancers.

Main Methods:

• Literature review of existing challenges and potential solutions for GBM personalized therapy.
• Analysis of factors hindering targeted treatment development in GBM.

Main Results:

• Significant hurdles exist for personalized GBM treatment, including the blood-brain barrier.
• Intra- and inter-tumoral heterogeneity presents a major obstacle.
• The need for more accurate and patient-representative animal models is critical.

Conclusions:

• Personalized molecular targeted medicine for GBM faces substantial challenges.
• Addressing the blood-brain barrier, tumor heterogeneity, and model relevance is essential for advancing GBM treatment.